Cannabinoids and Genetic Epilepsy Models: A Review with Focus on CDKL5 Deficiency Disorder
Abstract Pediatric genetic epilepsies, such as CDKL5 Deficiency Disorder (CDD), are severely debilitating, with early-onset seizures occurring more than ten…
Abstract Pediatric genetic epilepsies, such as CDKL5 Deficiency Disorder (CDD), are severely debilitating, with early-onset seizures occurring more than ten…
Abstract Background: Controversy exists whether prophylactic drugs are necessary in the treatment of medication overuse headache (MOH). Objectives: To determine…
Abstract Cannabidiol (CBD), a non-psychotropic main component of the Cannabis plant, has been approved as a drug in the European…
Abstract Cannabidiol (CBD) is a non-psychotropic cannabinoid with multiple pharmacological properties. Cannabidiol has attracted growing attention in the cosmetic industry,…
Abstract Background: Clinical depression is a serious public health issue that affects 4.7 % of the world’s population and can…
Abstract Supplementary Information: The online version contains supplementary material available at 10.1007/s00262-024-03801-7. Article type: Review Article Keywords: GPCRs, Immune checkpoint…
Abstract Light is crucial for higher plants, driving photosynthesis and serving as a powerful sensory signal that profoundly modulates growth,…
Abstract The increasing use of illicit drugs has become a major global concern. Illicit drugs interact with the brain and…
Abstract Cannabis sativa emerges as a noteworthy candidate for its medicinal potential, particularly in wound healing. This review article explores…
Abstract Background: Astrocytic reactivity in substance use disorders (SUDs) has been extensively studied, yet the molecular effect of delta-9-tetrahydrocannabinol (∆9-THC,…